Aim To determine characteristics associated with more severe outcomes in a global registry
of people with systemic lupus erythematosus (SLE) and COVID-19. Methods People with …

Abstract Purpose of Review To summarize current knowledge of the impact of coronavirus
disease 19 (COVID-19) on patients with systemic lupus erythematosus (SLE). Recent …

Objective To characterize patients with systemic lupus erythematosus (SLE) affected by
coronavirus disease 2019 (COVID‐19) and to analyze associations of comorbidities and …

Objectives To determine the severity and outcome of COVID-19 among individuals with
lupus as compared to controls. The secondary objective was to identify the risk association …

As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

Background Systemic lupus erythematosus (SLE) is a chronic disease characterised by
autoimmunity and increased susceptibility to infections. COVID-19 is a systemic viral …

The global health emergency generated by the SARS-CoV-2 outbreak has complicated the
management of patients with comorbidities, which together with old age seem to be the …

Background: Patients with systemic lupus erythematosus (SLE) have an increased risk of
infections due to impaired immune functions, disease activity, and treatment. This study …

Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the
impact of the COVID-19 pandemic on disease management. We conducted this overview by …

The COVID-19 pandemic has spread across New York City, NY, USA, affecting more than
150 000 of its 8· 5 million inhabitants as of April 26, 2020. 1 Severe illness resulting in …